SARS-CoV-2 Evolution and Immune Escape in Immunocompromised Patients

N Engl J Med. 2022 Jun 23;386(25):2436-2438. doi: 10.1056/NEJMc2202861. Epub 2022 Jun 8.

Authors

Erin M Scherer¹, Ahmed Babiker¹, Max W Adelman¹, Brent Allman¹, Autum Key¹, Jennifer M Kleinhenz¹, Rose M Langsjoen¹, Phuong-Vi Nguyen¹, Ivy Onyechi¹, Jacob D Sherman¹, Trevor W Simon¹, Hannah Soloff¹, Jessica Tarabay², Jay Varkey³, Andrew S Webster³, Daniela Weiskopf⁴, Daniel B Weissman⁵, Yongxian Xu⁵, Jesse J Waggoner⁵, Katia Koelle⁵, Nadine Rouphael⁵, Stephanie M Pouch⁵, Anne Piantadosi⁵

Affiliations

¹ Emory University, Atlanta, GA emscher@emory.edu.
² Emory Healthcare, Atlanta, GA.
³ Emory University, Atlanta, GA.
⁴ La Jolla Institute for Immunology, La Jolla, CA.
⁵ Emory University, Atlanta, GA anne.piantadosi@emory.edu.

No abstract available

Publication types

Letter

MeSH terms

Antibodies, Viral
Antigenic Drift and Shift
COVID-19*
Evolution, Molecular*
Humans
Immunocompromised Host
Neutralization Tests
SARS-CoV-2*

Substances

Antibodies, Viral

Grants and funding